UBS Starts Apollo Global Management (APO) at Buy; Alternatives Leader at Discount Valuation
Get Alerts APO Hot Sheet
Price: $140.76 -1.96%
Rating Summary:
21 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS initiates coverage on Apollo Global Management (NYSE: APO) with a Buy. PT $21.
UBS analyst says, "We view APO as a premiere alternative asset manager that should benefit from an increasing demand for alternatives, the company’s established track record of superior returns, its disciplined investment approach in particular during challenging periods, and the expansion of its product offerings. Primary risks include market sensitivity, competition, regulation, and difficulty to value the company given the limited visibility into future investments and returns."
For more ratings news on Apollo Global Management click here and for the rating history of Apollo Global Management click here.
Shares of Apollo Global Management closed at $17.97 yesterday.
UBS analyst says, "We view APO as a premiere alternative asset manager that should benefit from an increasing demand for alternatives, the company’s established track record of superior returns, its disciplined investment approach in particular during challenging periods, and the expansion of its product offerings. Primary risks include market sensitivity, competition, regulation, and difficulty to value the company given the limited visibility into future investments and returns."
For more ratings news on Apollo Global Management click here and for the rating history of Apollo Global Management click here.
Shares of Apollo Global Management closed at $17.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Freenome Inc. (FRNM) at Buy
- UBS Starts Schrodinger (SDGR) at Neutral
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share